Adaptive Biotechnologies (ADPT) EBITDA Margin Growth (3y) (2021 - 2026)
Adaptive Biotechnologies (ADPT) EBITDA Margin Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -2,915.00 |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 233.00 |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | -292.00 |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 63.00 |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 4,255.00 |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | -56.00 |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | -51.00 |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 2,504.00 |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | -73.00 |
| 10 | Adaptive Biotechnologies | 3.48 Bn | 3.27 Bn | 52.17 Mn | 8,392.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8,392.00 |
| Dec 31, 2025 | 6,853.00 |
| Sep 30, 2025 | 12,021.00 |
| Jun 30, 2025 | 10,994.00 |
| Mar 31, 2025 | 14,573.00 |
| Dec 31, 2024 | 18,400.00 |
| Sep 30, 2024 | 13,149.00 |
| Jun 30, 2024 | 10,310.00 |
| Mar 31, 2024 | 4,008.00 |
| Dec 31, 2023 | 12,481.00 |
| Sep 30, 2023 | 6,221.00 |
| Jun 30, 2023 | -14,647.00 |
| Mar 31, 2023 | 6,702.00 |
| Dec 31, 2022 | 2,892.00 |
| Sep 30, 2022 | -2,570.00 |
| Jun 30, 2022 | -4,750.00 |
| Mar 31, 2022 | -504.00 |
| Dec 31, 2021 | -8,012.00 |
| Sep 30, 2021 | -8,942.00 |
| Jun 30, 2021 | -1,416.00 |